Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 4 open reading frame 33 is a protein-coding gene (NCBI Gene ID: 132321; UniProt Q8N1A6) located on 4q28.2 in the human genome. It encodes a small, likely monomeric protein, currently without a defined structure, molecular family, or known biological function in humans[1][2][5]. C4orf33 belongs to a large class of “open reading frame” genes often identified by genome sequencing projects but not functionally characterized. There are no established roles in disease, no evidence for therapeutic targeting, and no widely accepted use as a clinical biomarker. Its expression profile, protein interactions, and regulatory mechanisms remain largely unstudied, placing it in the category of uncharacterized or putative proteins[1][2][5]. In summary, chromosome 4 open reading frame 33 (C4orf33) is a correct but uncharacterized human protein-coding gene with no recognized role as a drug target, biomarker, or disease-associated protein to date[1][2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 4 open reading frame 33 (C4orf33).